Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 |
|---|---|---|---|---|---|---|
| Revenue | 316M | 321M | 323M | 302M | 303M | 310M |
| Cost of revenue | 193M | 199M | 205M | 190M | 191M | 202M |
| Gross profit | 123M | 121M | 118M | 112M | 112M | 108M |
| Research and development | 14M | 14M | 14M | 13M | 13M | 13M |
| Selling, general and administrative | 79M | 79M | 74M | 72M | 71M | 71M |
| Operating expenses | 93M | 94M | 87M | 85M | 84M | 84M |
| Operating income | 30M | 27M | 31M | 27M | 28M | 24M |
| Pre-tax income | 32M | 29M | 32M | 31M | 30M | 25M |
| Income tax | 9M | 6M | 8M | 8M | 8M | 6M |
| Net income | 22M | 21M | 22M | 22M | 20M | 17M |
| Earnings per share | 0.87 | 0.84 | 0.89 | 0.86 | 0.81 | 0.68 |
| Earnings per share, diluted | 0.87 | 0.84 | 0.89 | 0.86 | 0.80 | 0.68 |
| Weighted average shares | 25M | 25M | 25M | 25M | 25M | 25M |
| Weighted average shares, diluted | 25M | 25M | 25M | 25M | 25M | 25M |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 215M | 210M | 189M | 227M | 200M | 248M | 243M | 255M |
| Receivables | 42M | 43M | 43M |
| Metric | 31 Jan 2026 | 31 Oct 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 |
|---|---|---|---|---|---|
| Operating cash flow | — | −10M | — | — | 164,000 |
| Depreciation and amortisation | 5M | 5M | 5M | 5M | 5M |
| Share-based compensation |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 45M |
| 43M |
| 45M |
| 42M |
| 42M |
| Current assets | 593M | 573M | 551M | 520M | 498M | 462M | 432M | 423M |
| Property, plant and equipment | 41M | 41M | 40M | 39M | 39M | 38M | 39M | 39M |
| Goodwill | 27M | 27M | 27M | 26M | 26M | 26M | 26M | 26M |
| Total assets | 698M | 678M | 655M | 626M | 601M | 576M | 555M | 550M |
| Current liabilities | 308M | 308M | 305M | 293M | 287M | 278M | 270M | 279M |
| Total liabilities | 310M | 310M | 307M | 296M | 290M | 281M | 272M | 284M |
| Equity | 358M | 340M | 336M | 305M | 286M | 284M | 271M | 256M |
| — |
| 2M |
| — |
| — |
| 912,000 |
| Capital expenditure | — | 6M | — | — | 5M |
| Investing cash flow | — | −9M | — | — | −9M |
| Dividends paid | — | 2M | — | — | 1M |
| Share buybacks | — | 8M | — | — | 2M |
| Financing cash flow | — | −9M | — | — | −4M |